Xilingio M 25mg/5mg/1000mg Tablet ER
Xilingio M 25mg/5mg/1000mg Tablet ER
Empagliflozin (25mg) + Linagliptin (5mg) + Metformin (1000mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Xilingio M 25mg/5mg/1000mg Tablet ER: A Comprehensive Solution for Type 2 Diabetes Management
Xilingio M (Empagliflozin 25mg + Linagliptin 5mg + Metformin 1000mg) is a once-daily, extended-release tablet formulation designed for managing Type 2 diabetes. It provides a comprehensive approach to glycemic control by targeting multiple pathways:
* Empagliflozin: This SGLT2 inhibitor helps reduce blood glucose levels by inhibiting the reabsorption of glucose in the kidneys.
* Linagliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor, this medication improves insulin secretion and reduces postprandial hyperglycemia.
* Metformin: The first-line treatment for Type 2 diabetes, metformin lowers blood glucose by increasing insulin sensitivity and reducing hepatic glucose production.
Xilingio M's unique ER formulation ensures consistent drug release throughout the day, minimizing fluctuations in blood sugar levels and improving patient convenience. This combination effectively addresses various aspects of Type 2 diabetes management for optimal glycemic control.
Consult your healthcare provider before taking Xilingio M. This product is not suitable for everyone with Type 2 diabetes.
Active composition
Empagliflozin 25 mg
+2 more active ingredients
About Empagliflozin
Empagliflozin is used to treat Type 2 diabetes. It works by inhibiting glucose reabsorption in the kidneys, promoting glucose excretion. Empagliflozin is effective in managing blood sugar levels. In summary, it plays a vital role in diabetes management.
How It Works
Empagliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the renal proximal tubules, reducing glucose reabsorption and increasing urinary glucose excretion.
All Active Ingredients
Linagliptin
Linagliptin inhibits the enzyme DPP-4, leading to increased levels of incretin hormones, which promote insulin secretion and inhibit glucagon release, thereby lowering blood glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
Customer Reviews
0 reviews for Xilingio M 25mg/5mg/1000mg Tablet ER